$0.8101
0.1115.73%
Last update: Nov 11, 10:57 AM
Metagenomi Therapeutics Inc
MGXNASDAQ
The average analyst price target for Metagenomi Therapeutics is $10.38, 1181.3% above the current price. Of 7 analysts, 6 rate it Buy and 1 Hold. Targets range from $5 to $23. The latest change came on Aug 11, 2026, when Wells Fargo lowered its price target on Metagenomi Therapeutics from $9 to $7 and kept an Overweight rating.
Price Target Range — 9 Quarters
Analyst Consensus — 7 Analysts
Rating Trend — Last 9 Months
